4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CANNOVUM CANNABIS AG I (27N0) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Berlin, Germany. Its market capitalization is roughly €1 million. In the fiscal year ended 2024-12-31, 27N0 reported €0M in revenue and (€0M) in net income.
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies.
Interactive charts & full statements →
| Income statement | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | €0M | €0M | €0M | €0M |
| Gross Profit | — | €0M | €0M | €0M |
| Operating Income (EBIT) | (€0M) | (€3M) | (€10M) | €0M |
| Net Income | (€0M) | (€3M) | (€10M) | (€0M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | €1M | €0M | €3M | €12M |
| Total Liabilities | €0M | €0M | €0M | €0M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 27N0 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms